GET THE APP

Structural Abnormalities of the Heart Occur During Fetal Development
..

Journal of Interventional and General Cardiology

ISSN: 2684-4591

Open Access

Perspective - (2023) Volume 7, Issue 4

Structural Abnormalities of the Heart Occur During Fetal Development

Caitlin Haxel*
*Correspondence: Caitlin Haxel, Department of Pediatric, University of Vermont, Burlington, USA, Email:
Department of Pediatric, University of Vermont, Burlington, USA

Received: 30-Jun-2023, Manuscript No. jigc-23-110684; Editor assigned: 03-Jul-2023, Pre QC No. P-110684; Reviewed: 14-Jul-2023, QC No. Q-110684; Revised: 19-Jul-2023, Manuscript No. R-110684; Published: 26-Jul-2023 , DOI: 10.37421/2684-4591.2023.7.195
Citation: Haxel, Caitlin. “Structural Abnormalities of the Heart Occur During Fetal Development.” J Interv Gen Cardiol 7 (2023): 195.
Copyright: © 2023 Haxel C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Congenital heart defects are structural abnormalities of the heart that occur during fetal development. With advances in medical care, more children with CHDs are surviving into adulthood, leading to a growing population of adults with congenital heart defects. However, providing adequate cardiology care for this population presents unique challenges. This article focuses on the cardiology care and loss to follow-up among adults with congenital heart defects in CH STRONG, a renowned medical institution. CH STRONG is a leading center that provides comprehensive care for patients with CHDs, from diagnosis and treatment in childhood to long-term follow-up in adulthood. Despite the availability of specialized care, loss to follow-up remains a significant concern among ACHD patients. Understanding the factors contributing to this phenomenon is crucial for improving healthcare delivery and patient outcomes. Several factors contribute to the loss to follow-up among ACHD patients in CH STRONG. One key factor is the transition from pediatric to adult cardiology care. The transition period often coincides with important life transitions, such as attending college, starting a career, or moving away from home.

Description

These transitions can disrupt patients' continuity of care and lead to a lack of awareness about the importance of ongoing cardiology follow-up. Additionally, ACHD patients may face financial barriers to accessing cardiology care. Many individuals in this population require lifelong medical management, including regular cardiology visits, diagnostic tests, and interventions. The costs associated with these services, coupled with the absence of comprehensive health insurance coverage, can lead to financial strain and result in missed or delayed appointments. Psychosocial factors also play a role in loss to follow-up. ACHD patients often deal with emotional and psychological challenges associated with their condition. Anxiety, depression, and coping with the uncertainty of their future can impact their motivation to engage in regular cardiology care. The lack of appropriate psychosocial support systems may exacerbate these challenges and contribute to non-compliance with follow-up appointments. This integrated care model ensures that patients receive appropriate and specialized treatment throughout their lives. The transition process is often complex and poorly coordinated, resulting in gaps in care [1].

Recognizing the significance of loss to follow-up, CH STRONG has implemented several strategies to improve cardiology care for ACHD patients. First, the institution has developed a structured transition program to facilitate the transfer of care from pediatric to adult cardiology services. This program includes dedicated transition clinics, educational resources and the involvement of both pediatric and adult cardiologists to ensure a smooth and informed transition process. Financial barriers are being addressed through various initiatives. CH STRONG collaborates with social workers, financial counselors, and patient advocacy organizations to help ACHD patients navigate insurance coverage options, access financial assistance programs, and develop personalized financial plans. Implementing structured transition programs that focus on educating patients and their families about the importance of adult cardiology care and providing support during the transition period can facilitate continuity of care. These efforts aim to alleviate the financial burden associated with long-term cardiology care and reduce barriers to follow-up [2].

To address psychosocial challenges, CH STRONG has integrated mental health services into its ACHD program. Mental health professionals with expertise in working with ACHD patients are available for consultation, counseling, and support. Additionally, patient support groups and online forums provide opportunities for ACHD patients to connect with peers, share experiences, and seek advice, fostering a sense of community and emotional well-being. Furthermore, CH STRONG utilizes innovative technological solutions to enhance follow-up care. Telemedicine services enable remote consultations, reducing the need for in-person visits, particularly for routine check-ups or followup discussions. Digital health platforms, including mobile applications and patient portals, allow ACHD patients to access their medical records, receive reminders for appointments, and communicate securely with their healthcare providers. Adults with CHDs may face psychosocial challenges, such as anxiety, depression, or social isolation. These factors can negatively impact their motivation to engage in ongoing cardiology care. These tools improve convenience and engagement, promoting regular cardiology care and reducing loss to follow-up [3].

Cardiology care and loss to follow-up among adults with congenital heart defects in CH STRONG are critical issues that warrant attention. The transition from pediatric to adult care, financial barriers, and psychosocial challenges significantly impact ACHD patients' continuity of care. However, CH STRONG has implemented various strategies to address these issues, including structured transition programs, financial support initiatives, mental health services, and technological solutions. By focusing on these strategies, CH STRONG aims to reduce loss to follow-up, enhance patient outcomes, and improve the overall quality of cardiology care for ACHD patients. Insufficient patient education can hinder their understanding of the importance of regular check-ups and preventive measures. Limited access to healthcare services due to financial constraints can impede regular cardiology care. High medical costs, insurance coverage gaps, and lack of financial resources can discourage individuals from seeking the necessary follow-up care. Continued research, collaboration, and advocacy in this field are crucial to further understanding the factors contributing to loss to follow-up and developing effective interventions that can be implemented on a broader scale to benefit ACHD patients worldwide [4].

Congenital heart defects are structural abnormalities of the heart that are present at birth. Thanks to advancements in medical care, more individuals with CHDs are now surviving into adulthood. However, the transition from pediatric to adult cardiology care poses unique challenges, resulting in loss to follow-up for many patients. This paper focuses on the importance of cardiology care and the issue of loss to follow-up among adults with CHDs in the Cardiology Hospital. Cardiology care plays a crucial role in the management and long-term outcomes of adults with CHDs. The complexity of CHDs requires specialized expertise, and regular cardiology evaluations are essential for detecting and managing potential complications. Patients may struggle to navigate the healthcare system, leading to missed appointments and disengagement from medical services. Many adults with CHDs are unaware of the potential long-term consequences of their condition or the necessity of ongoing cardiology care. These individuals may require lifelong monitoring, medication management, and interventions, such as catheterizations or surgeries, to optimize their cardiac health. The Cardiology Hospital provides comprehensive care for patients with CHDs, offering a multidisciplinary approach that includes cardiologists, congenital heart surgeons, and other healthcare professionals [5].

Conclusion

Enhancing patient education initiatives, both during the transition process and throughout adulthood, can help individuals understand the long-term implications of their condition and the necessity of ongoing cardiology care. Developing financial assistance programs or working with insurance providers to ensure adequate coverage for cardiology care can help mitigate financial barriers and ensure access to necessary services. Integrating mental health services into cardiology care can help address the psychosocial challenges faced by adults with CHDs, fostering better engagement and reducing the risk of loss to followup. Ensuring adequate cardiology care and reducing loss to follow-up among adults with CHDs in CH STRONG is crucial for improving their long-term health outcomes. By implementing seamless transition programs, enhancing patient education, providing financial support, and offering psychosocial assistance, healthcare providers can create a supportive environment that promotes regular engagement in cardiology care. It is essential to recognize the unique needs of this patient population and implement tailored interventions to minimize loss to follow-up, ultimately improving their quality of life and reducing the burden of complications associated with CHDs.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Lu, Guangli, Zhen Wu, Jia Shang and Zhenxing Xie, et al. "The effects of metformin on autophagy."Biomed Pharmacother137 (2021): 111286.
  2. Google Scholar, Crossref, Indexed at

  3. Mack, Molly and Ambarish Gopal. "Epidemiology, traditional and novel risk factors in coronary artery disease."Heart Fail Clin12 (2016): 1-10.
  4. Google Scholar, Crossref, Indexed at

  5. Przykaza, Łukasz. "Understanding the connection between common stroke comorbidities, their associated inflammation, and the course of the cerebral ischemia/reperfusion cascade."Front Immunol 12 (2021): 782569.
  6. Google Scholar, Crossref, Indexed at

  7. Zhang, Ying, Xue Liu, Lu Zhang and Xuelian Li, et al. "Metformin protects against H2O2-induced cardiomyocyte injury by inhibiting the miR-1a-3p/GRP94 pathway."Mol Ther Nucleic Acids 13 (2018): 189-197.
  8. Google Scholar, Crossref, Indexed at

  9. Chen, Qun, Jeremy Thompson, Ying Hu and Edward J. Lesnefsky. "Chronic metformin treatment decreases cardiac injury during ischemia-reperfusion by attenuating endoplasmic reticulum stress with improved mitochondrial function."Aging 13 (2021): 7828.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 11

Journal of Interventional and General Cardiology received 11 citations as per Google Scholar report

Journal of Interventional and General Cardiology peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward